Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes

PLoS Genetics

Volumn 8, Issue 6, 2012, Pages

  Simeonova, Iva ^a,b,c   Lejour, Vincent ^a,b,c   Bardot, Boris ^a,b,c   Bouarich Bourimi, Rachida ^a,b,c   Morin, Aurélie ^a,b,c   Fang, Ming ^a,b,c   Charbonnier, Laure ^a,b,c   Toledo, Franck ^a,b,c  

^a INSTITUT CURIE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Institut Curie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P130; PROTEIN P53; NCOA1 PROTEIN, HUMAN; RBL2 PROTEIN, MOUSE; STEROID RECEPTOR COACTIVATOR 1; TP53 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EMBRYO; GENE; GENE CLUSTER; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC REGULATION; HUMAN; HUMAN CELL; KLHL26 GENE; MOLECULAR EVOLUTION; MOUSE; NCOA1 GENE; NONHUMAN; RAT; RETINOBLASTOMA LIKE 2 GENE; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; TANDEM REPEAT; TRANSACTIVATION; ANIMAL; CELL CULTURE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; INTRON; METABOLISM; MUTATION; RETINOBLASTOMA;

MAMMALIA; MURINAE; MUS;

ANIMALS; CELLS, CULTURED; EVOLUTION, MOLECULAR; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTRONS; MICE; MUTATION; NUCLEAR RECEPTOR COACTIVATOR 1; RESPONSE ELEMENTS; RETINOBLASTOMA; RETINOBLASTOMA-LIKE PROTEIN P130; SPECIES SPECIFICITY; TANDEM REPEAT SEQUENCES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864067893     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002731     Document Type: Article

References (42)

1. Knudson AG Jr, (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437-1443.
2. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, et al. (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
3. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, et al. (1992) Effects of an Rb mutation in the mouse. Nature 359: 295-300.
4. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, et al. (1994) Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9: 1021-1027.
5. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12: 1599-1609.
6. Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, et al. (2004) Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5: 539-551.
7. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, et al. (2004) Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18: 1681-1694.
8. Zhang J, Schweers B, Dyer MA, (2004) The first knockout mouse model of retinoblastoma. Cell Cycle 3: 952-959.
9. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T, (2003) Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424: 223-228.
10. Spencer C, Pajovic S, Devlin H, Dinh QD, Corson TW, et al. (2005) Distinct patterns of expression of the RB gene family in mouse and human retina. Gene Expr Patterns 5: 687-694.
11. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA, (2006) Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 4: 14.
12. Ajioka I, Martins RA, Bayazitov IT, Donovan S, Johnson DA, et al. (2007) Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131: 378-390.
13. Dyer MA, Rodriguez-Galindo C, Wilson MW, (2005) Use of preclinical models to improve treatment of retinoblastoma. PLoS Med 2: e332 doi:10.1371/journal.pmed.0020332.
14. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, et al. (2006) Inactivation of the p53 pathway in retinoblastoma. Nature 444: 61-66.
15. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.
16. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B, (1992) Definition of a consensus binding site for p53. Nat Genet 1: 45-49.
17. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
18. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
19. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, et al. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36: 3639-3654.
20. Bourdon JC, Deguin-Chambon V, Lelong JC, Dessen P, May P, et al. (1997) Further characterisation of the p53 responsive element-identification of new candidate genes for trans-activation by p53. Oncogene 14: 85-94.
21. Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, et al. (2007) Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci U S A 104: 18613-18618.
22. Bourque G, Leong B, Vega VB, Chen X, Lee YL, et al. (2008) Evolution of the mammalian transcription factor binding repertoire via transposable elements. Genome Res 18: 1752-1762.
23. Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M, (2002) A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat Genet 30: 315-320.
24. Kolpakov R, Bana G, Kucherov G, (2003) mreps: Efficient and flexible detection of tandem repeats in DNA. Nucleic Acids Res 31: 3672-3678.
25. Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W, et al. (2006) Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 13: 324-334.
26. Helmbold H, Komm N, Deppert W, Bohn W, (2009) Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 28: 3456-3467.
27. Kunarso G, Chia NY, Jeyakani J, Hwang C, Lu X, et al. (2010) Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 42: 631-634.
28. Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, et al. (2011) The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 7: e1001360 doi:10.1371/journal.pgen.1001360.
29. Lee KH, Li M, Michalowski AM, Zhang X, Liao H, et al. (2010) A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci U S A 107: 69-74.
30. Ho VM, Schaffer BE, Karnezis AN, Park KS, Sage J, (2009) The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras. Oncogene 28: 1393-1399.
31. Schaffer BE, Park KS, Yiu G, Conklin JF, Lin C, et al. (2010) Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res 70: 3877-3883.
32. Pellegrini M, Renda ME, Vecchio A, (2010) TRStalker: an efficient heuristic for finding fuzzy tandem repeats. Bioinformatics 26: i358-366.
33. Xu J, Wu RC, O'Malley BW, (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615-630.
34. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
35. The Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
36. Le MT, Shyh-Chang S, LingKaw S, Chin L, Teh C, et al. (2011) Conserved regulation of p53 network dosage by MicroRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet 7: e1002242 doi:10.1371/journal.pgen.1002242.
37. Vinces MD, Legendre M, Caldara M, Hagihara M, Verstrepen KJ, (2009) Unstable tandem repeats in promoters confer transcriptional evolvability. Science 324: 1213-1216.
38. Gemayel R, Vinces MD, Legendre M, Verstrepen KJ, (2010) Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu Rev Genet 44: 445-477.
39. Post SM, Quintas-Cardama A, Pant V, Iwakuma T, Hamir A, et al. (2010) A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell 18: 220-230.
40. Hu W, Feng Z, Teresky AK, Levine AJ, (2007) p53 regulates maternal reproduction through LIF. Nature 450: 721-724.
41. Riley T, Yu X, Sontag E, Levine A, (2009) The p53HMM algorithm: using profile hidden markov models to detect p53-responsive genes. BMC Bioinformatics 10: 111.
42. Jaiswal AS, Narayan S, (2001) p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents. J Biol Chem 276: 18193-18199.